Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 can cause various skin issues, like rashes and hair loss, which help in early diagnosis.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The model and estimator can predict drug exposure in kidney transplant patients well.

Skin rashes can help diagnose COVID-19 early.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Cold-pressed rapeseed oil is most resistant to oxidation and certain oils may reduce chronic disease risk; consumers like the taste of pumpkin oil best.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Patients with multiple superficial venous thrombosis are at greater risk for serious complications like cancer and recurrent blood clots.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

Anti-phospholipid antibodies in SLE can cause thrombosis and bone necrosis.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

A woman developed severe skin damage after using a blood thinner called low-molecular-weight heparin.

The patient has a leg condition caused by vein issues, needing lifestyle changes and leg care.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

Skin diseases like alopecia areata and psoriasis may be linked to blood clotting issues and heart problems.